Company Description
FendX Technologies Inc. (trading in the U.S. under the symbol FDXTD) is described as a surface protection company that focuses on developing technology-based solutions intended to help reduce the spread of harmful pathogens and support cleaner, safer environments. The company is associated with the specialty chemicals industry within the broader basic materials sector through its work on coatings, films and related surface treatment technologies.
According to company disclosures, FendX concentrates on proprietary technologies that modify or protect surfaces so that pathogens are less likely to adhere or be transmitted. Its work spans multiple product formats, including films, coatings and cleaning products, all positioned around hygiene and pathogen reduction on high-touch or medically relevant surfaces.
Core technologies and product pipeline
FendX reports that it is advancing an eco-friendly, smart sponge designed to deliver effective cleaning while aiming to minimize environmental impact. This sponge is described as part of a broader hygiene-focused pipeline. The company states that it holds an exclusive supply agreement for this eco-sponge and an exclusive license to certain intellectual property related to its use.
In addition to cleaning products, FendX highlights REPELWRAP™ film, which it describes as a protective surface coating with repelling properties that significantly reduce adhesion and transmission of pathogens on high-touch surfaces. The company also references a spray-based coating with similar functionality, intended to provide a protective layer that limits pathogen adherence.
FendX further notes that it is developing specialized catheter coatings. Its disclosures refer to work on coatings for medical catheters, with its first coating being for Foley catheters. These coatings are described as designed to create a low friction surface that can enhance patient comfort during insertion and play a role in reducing microbial growth on catheter surfaces, which is considered an important factor in infection risk.
Intellectual property and licensing
The company emphasizes that it holds exclusive worldwide licenses and intellectual property for its coating technologies. This includes intellectual property associated with REPELWRAP™ film, spray-based coatings and catheter coatings, as well as the exclusive supply and IP rights related to the eco-sponge product. FendX also reports that a provisional patent application titled "Lubricated Dilated Medical Catheters and Cannula and Uses Thereof" was filed with the United States Patent and Trademark Office, listing FendX as the assignee.
By focusing on proprietary surface protection technologies and related intellectual property, FendX positions itself around the development and potential commercialization of pathogen-repelling or pathogen-reducing products intended for everyday environments and medical settings.
Business context for investors
From an investor perspective, FDXTD represents exposure to a company that describes its business around surface protection and pathogen reduction technologies. Its activities, as described in public communications, center on research, development and licensing of coatings, films and cleaning products rather than on generic commodity chemicals.
The company’s association with the specialty chemicals industry is based on its work with functional coatings and films designed for specific performance characteristics, such as reduced pathogen adhesion, low friction surfaces for medical devices and eco-focused cleaning capabilities.
FDXTD stock and market classification
FDXTD is the U.S. trading symbol linked to FendX Technologies Inc., which is also listed on the Canadian Securities Exchange under a different symbol and on a European market under another symbol, according to company news disclosures. Within stock market classification systems, it aligns with the basic materials sector and the specialty chemicals industry due to its emphasis on surface-related chemical technologies.
Key themes in FendX’s strategy
Based on available information, several themes recur in FendX’s description of its business:
- Surface protection focus: The company consistently characterizes itself as a surface protection company, highlighting technologies that alter surfaces to reduce pathogen adhesion and transmission.
- Hygiene and pathogen reduction: Its products and pipeline, including REPELWRAP™ film, spray-based coatings, catheter coatings and the eco-sponge, are all described in the context of reducing the spread of harmful pathogens.
- Medical and everyday environments: FendX references both everyday environments, such as high-touch surfaces, and specialized medical applications, such as Foley catheters.
- Intellectual property-driven model: The company underscores its exclusive licenses, supply agreements and patent filings as central to its approach.
Risk and forward-looking considerations
Company communications note that statements about product development, potential benefits and goals are forward-looking and subject to risks and uncertainties. These statements indicate that product candidates, including coatings and cleaning products, are under development and that expectations about pathogen reduction or other benefits may not be guaranteed.
How FDXTD fits in the specialty chemicals space
Within the specialty chemicals category, FendX’s described activities focus on functional surface treatments rather than bulk materials. Its emphasis on pathogen-repelling films, coatings and cleaning products places it in a niche that combines materials science, hygiene and medical device-related applications.
Investors researching FDXTD can use this context to understand that the company’s narrative centers on proprietary surface technologies, exclusive licensing arrangements and a pipeline of products aimed at addressing pathogen transmission on various surfaces.
Stock Performance
FendX Technologies (FDXTD) stock last traded at $0.5520. Over the past 12 months, the stock has lost 8.0%. At a market capitalization of $5.2M, FDXTD is classified as a micro-cap stock with approximately 9.0M shares outstanding.
Latest News
FendX Technologies has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all FDXTD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in FendX Technologies (FDXTD) currently stands at 7.6 thousand shares, up 100.4% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 100.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for FendX Technologies (FDXTD) currently stands at 1.0 days, down 82.7% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 82.7% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 5.8 days.
FDXTD Company Profile & Sector Positioning
FendX Technologies (FDXTD) operates in the Specialty Chemicals industry within the broader Basic Materials sector and is listed on the OTC Link.
Investors comparing FDXTD often look at related companies in the same sector, including Noho (DRNK), Tor Minerals (TORM), FendX Technologies Inc (FDXTF), Sonovia Israel (SNVIF), and Nano Magic Inc (NMGX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FDXTD's relative position within its industry.